10x Genomics Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
10x Genomics has a total shareholder equity of $722.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $937.8M and $215.0M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$398.16m |
| Aandelen | US$722.80m |
| Totaal verplichtingen | US$214.99m |
| Totaal activa | US$937.79m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 0A88's short term assets ($593.9M) exceed its short term liabilities ($121.2M).
Langlopende schulden: 0A88's short term assets ($593.9M) exceed its long term liabilities ($93.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 0A88 is debt free.
Schuld verminderen: 0A88 has no debt compared to 5 years ago when its debt to equity ratio was 7%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Whilst unprofitable 0A88 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Voorspelling contante baan: 0A88 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 1% per year.